The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III. 1982

M J Griffith

The heparin-enhanced antithrombin III/thrombin reaction was studied under experimental conditions where the dependence of the reaction velocity on the concentrations of thrombin and antithrombin III could be determined. The results have shown that the reaction is saturable with respect to both thrombin (KT = 3.6 x 10(-8) M) and antithrombin III (KAT = 1.0 x 10(-7) M) when the heparin concentration is low relative to the initial protein concentrations. The apparent first order rate constant for the rate-limiting step in the reaction was approximately 800 min-1. The reaction was subject to inhibition by antithrombin III/thrombin, the product of the reaction. Inhibition appeared to be noncompetitive with respect to antithrombin II with KP, the apparent heparin product dissociation constant, approximately equal to KT. When the heparin-enhanced antithrombin III/thrombin reaction was studied under conditions where the heparin concentration was high relative to the initial protein concentrations the overall reaction was second order. The initial reaction velocity, under any set of experimental conditions, could be described by the general rate equation for a random order bireactant, enzyme-catalyzed reaction, which is mathematically identical with the "template" model for the mechanism of action of heparin (Griffith, M. J. (1982) J. Biol. Chem. 257, 7360-7365).

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

M J Griffith
July 1976, Archives of biochemistry and biophysics,
M J Griffith
January 1977, Federation proceedings,
M J Griffith
January 1985, Acta biochimica et biophysica; Academiae Scientiarum Hungaricae,
M J Griffith
January 1980, Thrombosis research,
M J Griffith
January 1979, Thrombosis research,
M J Griffith
January 1975, Biochimica et biophysica acta,
Copied contents to your clipboard!